Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)

Objective: To compare the differences in adverse effects and efficacy profile between bacillus Calmette-Guerin (BCG) Danish 1331 and BCG Moscow-I strain in management of non-muscle invasive bladder cancer. Methods: Clinical data of 188 cases of non-muscle invasive bladder cancer treated with BCG bet...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Yuvaraja B. Thyavihally, Preetham Dev, Santosh Waigankar, Abhinav Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani, Ashishkumar Asari
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2022-04-01
سلاسل:Asian Journal of Urology
الموضوعات:
Adjuvant bacillus Calmette-Guerin
Bacillus Calmette-Guerin adverse effects
Danish 1331 strain
Intravesical therapy
Moscow-I strain
Non-muscle invasive bladder cancer
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2214388221000394
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة